CATALOGO DEI PRODOTTI DELLA RICERCA

LANDONI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.518
NA - Nord America 4.327
AS - Asia 3.220
SA - Sud America 492
AF - Africa 76
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.206
RU - Federazione Russa 2.447
SG - Singapore 1.283
CN - Cina 1.100
IT - Italia 805
GB - Regno Unito 658
BR - Brasile 405
DE - Germania 365
SE - Svezia 322
HK - Hong Kong 298
IE - Irlanda 265
FR - Francia 247
VN - Vietnam 205
FI - Finlandia 147
KR - Corea 79
CA - Canada 73
NL - Olanda 61
JP - Giappone 54
IN - India 48
MX - Messico 36
UA - Ucraina 35
PL - Polonia 30
AR - Argentina 26
TR - Turchia 26
ES - Italia 22
ID - Indonesia 20
ZA - Sudafrica 20
AT - Austria 19
BE - Belgio 19
BD - Bangladesh 18
CZ - Repubblica Ceca 17
IQ - Iraq 15
TG - Togo 15
CL - Cile 13
LT - Lituania 13
CO - Colombia 12
PK - Pakistan 11
VE - Venezuela 11
BJ - Benin 10
AU - Australia 9
UZ - Uzbekistan 9
EC - Ecuador 8
NP - Nepal 8
CH - Svizzera 7
EG - Egitto 7
IR - Iran 7
PE - Perù 7
TN - Tunisia 7
AZ - Azerbaigian 6
IL - Israele 6
RO - Romania 6
DK - Danimarca 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
LV - Lettonia 4
PY - Paraguay 4
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
GA - Gabon 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
LC - Santa Lucia 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 13.639
Salva come PNG Salva come JPEG
Città #
Moscow 905
Dallas 669
Singapore 659
Chandler 646
Southend 548
Ashburn 447
Hong Kong 297
Dublin 254
Beijing 220
Verona 182
New York 156
Jacksonville 152
Munich 134
Los Angeles 120
Ann Arbor 102
Woodbridge 101
The Dalles 86
Ho Chi Minh City 82
Helsinki 77
Lawrence 75
Princeton 75
Jinan 67
Wilmington 64
Shenyang 55
Houston 53
São Paulo 53
Santa Clara 50
Nanjing 49
Redmond 48
Milan 47
Hanoi 45
Tokyo 43
Turku 41
Redondo Beach 40
Sindelfingen 40
Rome 38
Tianjin 37
Bologna 34
Columbus 33
Hebei 33
Denver 32
Haikou 30
London 28
Hangzhou 27
Seattle 27
Washington 27
Warsaw 26
Taiyuan 25
Montreal 24
Ningbo 24
Phoenix 24
Guangzhou 23
Amsterdam 22
Buffalo 22
Toronto 22
Changsha 21
Orem 21
Stockholm 21
Zhengzhou 21
Chicago 20
Nanchang 20
Brussels 19
Chennai 19
Seoul 19
Mexico City 18
Belo Horizonte 17
Council Bluffs 17
Brooklyn 16
Johannesburg 16
Poplar 16
Redwood City 16
Atlanta 15
Lomé 15
Nuremberg 15
Rio de Janeiro 15
Boardman 14
Brno 14
San Francisco 14
Taizhou 14
Fairfield 13
Falkenstein 13
Frankfurt am Main 12
Manchester 12
Florence 11
Boston 10
Cotonou 10
Curitiba 10
Falls Church 10
Jiaxing 10
Kent 10
Vienna 10
Vito 10
Ankara 9
Fuzhou 9
Meda 9
Mumbai 9
Ottawa 9
San Jose 9
Brescia 8
Dong Ket 8
Totale 7.864
Salva come PNG Salva come JPEG
Nome #
ULCERE DIFFICILI DEGLI ARTI INFERIORI: UN CASO DI ERITEMA INDURATO DI BAZIN 374
Whole-genome landscape of pancreatic neuroendocrine tumours 253
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 218
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 217
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 214
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 214
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 209
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 208
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 205
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 202
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 201
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 190
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 189
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 186
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 186
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 186
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 180
ANOMALIE ASSOCIATE DELL'APPENDICE VERMIFORME. DESCRIZIONE E DISCUSSIONE DI UN CASO 179
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 178
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 173
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 169
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 168
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 167
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 167
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 167
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 166
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 166
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 165
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 162
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 158
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 158
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 157
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 156
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 154
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 154
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 153
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 147
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 146
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 145
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 144
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 142
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 141
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 141
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 141
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 140
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 140
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 140
TREATMENT OF SIX HEPATIC ARTERY ANEURYSMS 139
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 139
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 139
Imaging presentation of pancreatic neuroendocrine neoplasms 138
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 138
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 137
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 136
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 136
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 134
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 133
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 133
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 132
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 132
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 130
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome 126
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 124
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 122
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 120
Negative pressure wound therapy for prevention of surgical site infection in patients at high risk after clean-contaminated major pancreatic resections: A single-center, phase 3, randomized clinical trial 120
Assessment of difficulty in laparoscopic distal pancreatectomy: a modification of the Japanese difficulty scoring system - A single-center high-volume experience 120
Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020 120
An Antibiotic Stewardship Program in Pancreatic Surgery 119
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 117
Long-term organoid culture of a small intestinal neuroendocrine tumor 116
Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios 115
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections 115
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 114
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 114
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 112
Pancreatic surgery is a safe teaching model for tutoring residents in the setting of a high-volume academic hospital: a retrospective analysis of surgical and pathological outcomes 108
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 105
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 105
Thirty-day prevalence and clinical impact of fluid collections at the resection margin after distal pancreatectomy: Follow-up of a multicentric randomized controlled trial 103
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 102
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 101
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 98
Outcomes of patients undergoing elective liver and pancreas cancer surgery during the SARS-CoV-2 pandemic: an international, multicentre, prospective cohort study 94
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 89
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 88
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study 87
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 87
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 82
Mortality and pulmonary complications in emergency general surgery patients with COVID-19: A large international multicenter study 82
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 80
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups 80
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 77
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 75
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 73
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 72
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 57
Pancreatic stump perfusion assessment using indocyanine green fluorescence and its impact on postoperative pancreatic fistula: A systematic review and meta-analysis 12
Totale 13.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.785
article - articoli 46.573
book - libri 0
conference - conferenze 2.212
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 75 21 23 44 25 55 46
2021/2022724 55 202 30 74 30 16 12 35 44 14 58 154
2022/20231.757 92 240 139 323 108 443 39 108 183 16 39 27
2023/20241.143 32 76 121 120 106 221 88 57 21 50 196 55
2024/20252.503 124 128 141 388 135 113 152 141 301 173 240 467
2025/20265.525 515 372 664 1.331 2.153 490 0 0 0 0 0 0
Totale 13.843